ClinicalTrials.gg
Active, not recruitingNCT03248921OPOSUpdated Jul 28, 2021

The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery

An observational study in Obesity, Cardiac Disease and Cardiovascular Syndromes, Metabolic, sponsored by Cardiovascular Research New Brunswick. Active, not recruiting at 1 site in Canada. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-07-28.

Sponsored by Cardiovascular Research New Brunswick · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
610
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to identify measures of obesity, functional capacity, and specific biomarkers that may be predictive of obesity and post-operative outcomes.

Read the detailed description

Background: Increasing levels of obesity worldwide have led to a rise in the prevalence of obesity-related complications including cardiovascular disease, diabetes, cancers etc. Health care providers believe that obesity has a negative effect on patients undergoing cardiac surgery, with overweight and obese patients being more likely to experience adverse post-operative outcomes. The body mass index (BMI) is the single most used measure for determining obesity classification in clinical practice, without accounting for a patient's level of cardiopulmonary fitness or muscle mass.

Study Design: Patients between the ages of 18 and 75 years undergoing elective cardiac surgery will be consented to participate in this prospective observational trial. Patients are invited to participate in measures of obesity, functional capacity and exercise capacity assessments, quality of life questionnaires, and blood and tissue sampling for biomarker analysis.

Endpoints: Measures other than BMI that could be predictive of short-term and long-term post-operative outcomes. Outcomes of interest include: prolonged length of ventilation, hospital length of stay and all-cause mortality.

Summary: The results of this trial will potentially identify an improved definition of fitness capacity for obese cardiac surgical patients and biomarkers alone or in combination that could identify the potential for adverse outcomes in patients undergoing cardiac surgery. This study will help clinicians better segregate and treat patients pre-operatively based on fitness levels and associated biomarkers.

02

Conditions studied

  • Obesity
  • Cardiac Disease
  • Cardiovascular Syndromes, Metabolic
03

In context

Obesity

6,570 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's planned enrollment of 610 is above the median of 132 across 1,338 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Cardiovascular Research New Brunswick is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients scheduled to undergo elective, first-time cardiac surgery will be considered for eligibility to participate in the study. As well, a patient whose BMI is less than 18.5 kg/m2 and classified as underweight by the World Health Organization will be excluded. Only those patients who are classified as being normal weight range or overweight and/or obese may be considered for eligibility to participate as defined by the study objectives regarding post-operative cardiac surgery outcomes in obese patients. Patients in the normal weight range classification will be included as a baseline control participant cohort. Finally, patients over the age of 75 will be excluded so as to eliminate the role that advanced age may play in affecting functional capacity.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Provide informed consent

      • Male or female patients who are > 18 years of age
      • Patients must be scheduled to undergo elective, first-time cardiac surgery during routine scheduling times

Exclusion criteria

Exclusion Criteria:

  • Patients who are > 75 years of age
  • BMI is less than 18.5 kg/m2 and classified as underweight according to the World Health Organization
  • Any non-elective first time cardiac surgery patient (eg. in-house urgent patients; emergent patients)
  • Any cardiac patients to undergo re-operation
  • Simultaneous participation in another study with an investigational study agent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
610 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • High-Fit obese

    Cardiac surgery patients will be segregated into the high-fit group based on 6 minute walk test distance and other measures of functional capacity

    Procedure: cardiac surgery

  • Low-Fit obese

    Cardiac surgery patients will be segregated into the low-fit group based on 6 minute walk test distance and other measures of functional capacity

    Procedure: cardiac surgery

Interventions

  • Procedurecardiac surgery

    cardiac surgery including non-emergency, elective coronary artery bypass grafting surgery with or without valve surgery, aortic or mitral valve surgery

06

What researchers measure

Primary outcomes

  1. Prolonged Hospitalization

    A length of stay of more than 5 days

    Time frame: post-operative day (POD) 30

  2. Prolonged ventilation > 24 hours

    mechanical ventilation for more than 24 hours of invasive (via endotracheal tube or tracheostomy) and/or noninvasive (facial/nasal interface) methods of delivery

    Time frame: post-operative day (POD) 30

Secondary outcomes

  1. all cause mortality

    Patient death, either in hospital or long-term

    Time frame: post-operative day (POD) 30 and 1 year post-op

  2. non fatal myocardial infarction

    Transmural, Subendocardial infarction

    Time frame: post-operative day (POD) 30 and 1 year post-op

  3. Stroke

    Transient, permanent

    Time frame: post-operative day (POD) 30

  4. Respiratory complications

    Pleural effusion, pneumonia

    Time frame: post-operative day (POD) 30

  5. Prolonged ICU length of stay

    length of stay of more than 48 hours

    Time frame: post-operative day (POD) 30

  6. Re-operation for any cause

    re-operation due to complications, bleeding and/or other reasons

    Time frame: post-operative day (POD) 30 and 1 year post-op

  7. Atrial fibrillation

    post-op occurrence requiring treatment

    Time frame: post-operative day (POD) 30 and 1 year post-op

  8. Post-operative length of stay and disposition on discharge

    home, home with care, transfer to other facility, or expired

    Time frame: post-operative day (POD) 30 and 1 year post-op

  9. Wound infection

    infection of sternum or other incisional access sites

    Time frame: post-operative day (POD) 30

07

Study locations

1 site
  • Saint John Regional Hospital
    Saint John, New Brunswick E2L 4L2, Canada
08

References and documents

Publications

  • Aguiar C, MacLeod J, Yip A, Melville S, Legare JF, Pulinilkunnil T, Kienesberger P, Brunt K, Hassan A. Impact of Obesity on Postoperative Outcomes following cardiac Surgery (The OPOS study): rationale and design of an investigator-initiated prospective study. BMJ Open. 2019 Mar 3;9(3):e023418. doi: 10.1136/bmjopen-2018-023418. PubMed 30833313 ↗
  • Sarkar S, Legere S, Haidl I, Marshall J, MacLeod JB, Aguiar C, Lutchmedial S, Hassan A, Brunt KR, Kienesberger P, Pulinilkunnil T, Legare JF. Serum GDF15, a Promising Biomarker in Obese Patients Undergoing Heart Surgery. Front Cardiovasc Med. 2020 Jun 24;7:103. doi: 10.3389/fcvm.2020.00103. eCollection 2020. PubMed 32671100 ↗

Related links

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03248921
Lead sponsor
Cardiovascular Research New Brunswick
Collaborators
Horizon Health Network, Maritime Heart Centre
Responsible party
Ansar Hassan, MD, PhD (Principal Investigator, Dalhousie University) — Principal investigator
First posted
Aug 15, 2017
Start date
Nov 2014
Primary completion
Nov 2025 (estimated)
Completion
Nov 2030 (estimated)
Last update
Jul 28, 2021

Study contacts

Ansar Hassan, MD, PhD
principal investigator · New Brunswick Heart Centre, Department of Cardiac Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion